Cargando…
Item response models for the longitudinal analysis of health-related quality of life in cancer clinical trials
BACKGROUND: The use of health-related quality of life (HRQoL) as an endpoint in cancer clinical trials is growing rapidly. Hence, research into the statistical approaches used to analyze HRQoL data is of major importance, and could lead to a better understanding of the impact of treatments on the ev...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5615461/ https://www.ncbi.nlm.nih.gov/pubmed/28950850 http://dx.doi.org/10.1186/s12874-017-0410-9 |
_version_ | 1783266590541742080 |
---|---|
author | Barbieri, Antoine Peyhardi, Jean Conroy, Thierry Gourgou, Sophie Lavergne, Christian Mollevi, Caroline |
author_facet | Barbieri, Antoine Peyhardi, Jean Conroy, Thierry Gourgou, Sophie Lavergne, Christian Mollevi, Caroline |
author_sort | Barbieri, Antoine |
collection | PubMed |
description | BACKGROUND: The use of health-related quality of life (HRQoL) as an endpoint in cancer clinical trials is growing rapidly. Hence, research into the statistical approaches used to analyze HRQoL data is of major importance, and could lead to a better understanding of the impact of treatments on the everyday life and care of patients. Amongst the models that are used for the longitudinal analysis of HRQoL, we focused on the mixed models from item response theory, to directly analyze raw data from questionnaires. METHODS: We reviewed the different item response models for ordinal responses, using a recent classification of generalized linear models for categorical data. Based on methodological and practical arguments, we then proposed a conceptual selection of these models for the longitudinal analysis of HRQoL in cancer clinical trials. RESULTS: To complete comparison studies already present in the literature, we performed a simulation study based on random part of the mixed models, so to compare the linear mixed model classically used to the selected item response models. As expected, the sensitivity of the item response models to detect random effects with lower variance is better than that of the linear mixed model. We then used a cumulative item response model to perform a longitudinal analysis of HRQoL data from a cancer clinical trial. CONCLUSIONS: Adjacent and cumulative item response models seem particularly suitable for HRQoL analysis. In the specific context of cancer clinical trials and the comparison between two groups of HRQoL data over time, the cumulative model seems to be the most suitable, given that it is able to generate a more complete set of results and gives an intuitive illustration of the data. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12874-017-0410-9) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-5615461 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-56154612017-09-28 Item response models for the longitudinal analysis of health-related quality of life in cancer clinical trials Barbieri, Antoine Peyhardi, Jean Conroy, Thierry Gourgou, Sophie Lavergne, Christian Mollevi, Caroline BMC Med Res Methodol Research Article BACKGROUND: The use of health-related quality of life (HRQoL) as an endpoint in cancer clinical trials is growing rapidly. Hence, research into the statistical approaches used to analyze HRQoL data is of major importance, and could lead to a better understanding of the impact of treatments on the everyday life and care of patients. Amongst the models that are used for the longitudinal analysis of HRQoL, we focused on the mixed models from item response theory, to directly analyze raw data from questionnaires. METHODS: We reviewed the different item response models for ordinal responses, using a recent classification of generalized linear models for categorical data. Based on methodological and practical arguments, we then proposed a conceptual selection of these models for the longitudinal analysis of HRQoL in cancer clinical trials. RESULTS: To complete comparison studies already present in the literature, we performed a simulation study based on random part of the mixed models, so to compare the linear mixed model classically used to the selected item response models. As expected, the sensitivity of the item response models to detect random effects with lower variance is better than that of the linear mixed model. We then used a cumulative item response model to perform a longitudinal analysis of HRQoL data from a cancer clinical trial. CONCLUSIONS: Adjacent and cumulative item response models seem particularly suitable for HRQoL analysis. In the specific context of cancer clinical trials and the comparison between two groups of HRQoL data over time, the cumulative model seems to be the most suitable, given that it is able to generate a more complete set of results and gives an intuitive illustration of the data. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12874-017-0410-9) contains supplementary material, which is available to authorized users. BioMed Central 2017-09-26 /pmc/articles/PMC5615461/ /pubmed/28950850 http://dx.doi.org/10.1186/s12874-017-0410-9 Text en © The Author(s) 2017 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Article Barbieri, Antoine Peyhardi, Jean Conroy, Thierry Gourgou, Sophie Lavergne, Christian Mollevi, Caroline Item response models for the longitudinal analysis of health-related quality of life in cancer clinical trials |
title | Item response models for the longitudinal analysis of health-related quality of life in cancer clinical trials |
title_full | Item response models for the longitudinal analysis of health-related quality of life in cancer clinical trials |
title_fullStr | Item response models for the longitudinal analysis of health-related quality of life in cancer clinical trials |
title_full_unstemmed | Item response models for the longitudinal analysis of health-related quality of life in cancer clinical trials |
title_short | Item response models for the longitudinal analysis of health-related quality of life in cancer clinical trials |
title_sort | item response models for the longitudinal analysis of health-related quality of life in cancer clinical trials |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5615461/ https://www.ncbi.nlm.nih.gov/pubmed/28950850 http://dx.doi.org/10.1186/s12874-017-0410-9 |
work_keys_str_mv | AT barbieriantoine itemresponsemodelsforthelongitudinalanalysisofhealthrelatedqualityoflifeincancerclinicaltrials AT peyhardijean itemresponsemodelsforthelongitudinalanalysisofhealthrelatedqualityoflifeincancerclinicaltrials AT conroythierry itemresponsemodelsforthelongitudinalanalysisofhealthrelatedqualityoflifeincancerclinicaltrials AT gourgousophie itemresponsemodelsforthelongitudinalanalysisofhealthrelatedqualityoflifeincancerclinicaltrials AT lavergnechristian itemresponsemodelsforthelongitudinalanalysisofhealthrelatedqualityoflifeincancerclinicaltrials AT mollevicaroline itemresponsemodelsforthelongitudinalanalysisofhealthrelatedqualityoflifeincancerclinicaltrials |